Just found a piece towards the end of the latest Annual Report - p61, released on 3 Oct 2022.
They already made a 'contingency liability' in the report of $144,825 for the case if they lose against Medcan, plus another 'unrecognised' amount of $158,175 which would also become payable to Medcan on losing.
So pretty much half of the figure has already been written off which isn't a good look while they're saying that they're confident of winning.
For CGB to be paying their auditor (Nexia) fees of $260,840 for the year, one would have thought they could share the calculator because this $144,825 + $158,175 still falls $30k short of the $333k amount being disputed. If it wasn't so tragic it'd be hilarious.
CGB Price at posting:
2.1¢ Sentiment: Hold Disclosure: Held